Shoji Sanada Selected Research

Shoji Sanada Research Topics

Disease

20	Heart Failure 01/2021 - 05/2003
14	Ischemia 12/2017 - 01/2002
14	Infarction (Infarctions) 12/2017 - 01/2002
12	Reperfusion Injury 12/2017 - 01/2002
9	Cardiomegaly (Heart Hypertrophy) 01/2016 - 01/2002
9	Myocardial Ischemia (Ischemic Heart Diseases) 05/2007 - 07/2002
7	Myocardial Infarction 12/2017 - 01/2002
7	Hypertrophy 01/2012 - 09/2002
6	Coronary Occlusion 12/2004 - 01/2002
5	Fibrosis (Cirrhosis) 01/2016 - 04/2006
3	Neoplasms (Cancer) 03/2016 - 03/2002
3	Ventricular Fibrillation 01/2005 - 01/2002
3	Body Weight (Weight, Body) 08/2004 - 09/2002
2	Inflammation (Inflammations) 01/2016 - 04/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Infections 10/2020
1	COVID-19 10/2020
1	Atherosclerotic Plaque (Atheroma) 11/2018
1	Bradycardia 12/2017
1	Hypotension (Low Blood Pressure) 12/2017
1	Cardiotoxicity 03/2016
1	Myocarditis (Carditis) 01/2016
1	Glucose Intolerance 05/2013
1	Diabetes Mellitus 05/2013
1	Cardiac Arrhythmias (Arrythmia) 04/2013

Drug/Important Bio-Agent (IBA)

9	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 03/2016 - 09/2002
6	Adenosine (Adenocard)FDA LinkGeneric 06/2008 - 01/2002
6	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2006 - 01/2002
5	5'-Nucleotidase (5' Nucleotidase)IBA 06/2008 - 09/2003
4	Nitric Oxide Synthase (NO Synthase)IBA 04/2006 - 01/2002
4	Phosphotransferases (Kinase)IBA 01/2005 - 09/2002
4	Raloxifene Hydrochloride (Evista)FDA Link 06/2004 - 01/2002
4	Selective Estrogen Receptor Modulators (SERM)IBA 06/2004 - 01/2002
3	Interleukin-33IBA 01/2017 - 06/2007
3	Pharmaceutical PreparationsIBA 01/2016 - 04/2005
3	Adenosine Triphosphate (ATP)IBA 06/2012 - 09/2002
3	Angiotensin IIIBA 01/2012 - 10/2003
3	Charybdotoxin (ChTX)IBA 12/2004 - 09/2002
3	8-(4-sulfophenyl)theophyllineIBA 10/2004 - 01/2002
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2003 - 09/2002
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2018 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 06/2010
2	Messenger RNA (mRNA)IBA 01/2016 - 07/2010
2	Anti-Arrhythmia AgentsIBA 04/2013 - 01/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 10/2004
2	Angiotensin Receptor AntagonistsIBA 01/2012 - 05/2003
2	Ion Channels (Ion Channel)IBA 11/2011 - 02/2010
2	Histamine (Histamine Dihydrochloride)FDA Link 11/2010 - 05/2006
2	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2010 - 06/2004
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2010 - 01/2002
2	Mineralocorticoid Receptor AntagonistsIBA 04/2006 - 05/2003
2	AldosteroneIBA 04/2006 - 07/2005
2	Protein Kinase CIBA 07/2005 - 07/2004
2	WortmanninIBA 01/2005 - 10/2004
2	Celiprolol (ST1396)IBA 08/2004 - 04/2003
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2003 - 01/2002
2	Endothelin-1 (Endothelin 1)IBA 10/2003 - 09/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2003 - 07/2002
2	PotassiumIBA 01/2003 - 09/2002
2	Hydralazine (Apresoline)FDA LinkGeneric 01/2003 - 09/2002
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2003 - 09/2002
1	empagliflozinIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 11/2018
1	neutravidinIBA 11/2018
1	Apolipoproteins E (ApoE)IBA 11/2018
1	Biotin (Vitamin H)FDA Link 11/2018
1	ApolipoproteinsIBA 11/2018
1	nitroxylIBA 12/2017
1	tempolIBA 12/2017
1	Free RadicalsIBA 12/2017
1	TEMPOIBA 12/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Liposomes (Liposome)IBA 01/2016
1	CytokinesIBA 01/2016
1	InterferonsIBA 01/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	human NPPA protein (carperitide)IBA 08/2014
1	DiureticsIBA 08/2014
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 08/2014
1	Peptides (Polypeptides)IBA 08/2014
1	VildagliptinIBA 05/2013
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 05/2013
1	Hormones (Hormone)IBA 05/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2013
1	IncretinsIBA 05/2013
1	Amiodarone (Amiodarona)FDA LinkGeneric 04/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2012
1	HydrogenIBA 06/2012

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2002
2	Intravenous Administration 04/2013 - 01/2005
2	Ligation 01/2012 - 04/2005
1	Ambulatory Care (Outpatient Care) 10/2020
1	Intravenous Injections 11/2018
1	Lasers (Laser) 11/2018